ArticleEuropean journal of case reports in internal medicine2026

Invariant Natural Killer T Cell-Based Immunotherapy Using α-Galactosylceramide-Pulsed CD14

Keigo Hanada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.